Clinical Trial Update: A Study to Evaluate Safety and Pharmacokinetics/Pharmacodynamics of Sustained Release(SR) Exenatide [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety and pharmacokinetics/pharmacodynamics of sustained-release exenatide in people with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Exenatide SR (exenatide)

Snippet

Sponsor: Peptron, Inc. | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED